国办印发深化医改重点任务推进国家组织药品集中采购和使用试点
据《新华社》报道,国务院办公厅印发《深化医药卫生体制改革2019年重点工作任务》,《任务》明确了两方面重点工作内容。
一是要研究制定的文件,主要涉及健康中国行动、促进社会办医健康规范发展、鼓励仿制的药品目录、规范医用耗材使用、以药品集中采购和使用为突破口进一步深化医改、医疗机构用药管理、互联网诊疗收费和医保支付、卫生专业技术人员职称制度改革、建立完善老年健康服务体系、二级及以下公立医疗机构绩效考核、加强医生队伍管理、医联体管理、公立医院薪酬制度改革、改进职工医保个人账户、医疗保障基金使用监管等方面的15个文件。
二是要推动落实的重点工作,主要围绕解决看病难、看病贵问题和加强医院管理等方面,提出21项具体工作。解决看病难方面,提出推进国家医学中心和区域医疗中心建设、有序发展医联体促进分级诊疗、深化「放管服」改革支持社会办医、促进「互联网+医疗健康」发展、统筹推进县域综合医改、实施健康中国行动、加强癌症等重大疾病防治等重点工作。
解决看病贵方面,提出推进国家组织药品集中采购和使用试点、推进高值医用耗材改革、巩固完善国家基本药物制度、推进医保支付方式改革、完善公立医院补偿机制、深化公立医院综合改革、深入实施健康扶贫等重点工作。加强医院管理方面,提出开展公立医院绩效考核、进一步改善医疗服务等重点工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.